Skip to main content
SpringerLink
Log in

Hormonal Therapy for Acne

  • Chapter
Pathogenesis and Treatment of Acne and Rosacea

Abstract

Androgens play an important role in acne vulgaris [1]. High levels of androgens and/or hypersensitivity of the sebaceous glands to normal androgen levels result in an increase of sebum production which is a prerequisite for acne in all patients [1–4].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 189.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 239.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 279.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Zouboulis CC. The human skin as a hormone target and an endocrine gland. Hormones. 2004;3:9–26.

    Article  PubMed  Google Scholar 

  2. Chen WC, Zouboulis CC. Hormones and the pilosebaceous unit. Dermatoendocrinology. 2009;1:81–6.

    Article  CAS  Google Scholar 

  3. Makrantonaki E, Ganceviciene R, Zouboulis C. An update on the role of the sebaceous gland in the pathogenesis of acne. Dermatoendocrinology. 2009;3:47–9.

    Google Scholar 

  4. Zouboulis CC. The skin as an endocrine organ. Dermatoendocrinol. 2009;1:250–2.

    Article  PubMed Central  PubMed  Google Scholar 

  5. Zouboulis CC, Chen WC, Thorton MJ, et al. Sexual hormones in human skin. Horm Metab Res. 2007;39:85–95.

    Article  CAS  PubMed  Google Scholar 

  6. Chen W, Thiboutot D, Zouboulis CC. Cutaneous androgen metabolism: basic research and clinical perspectives. J Invest Dermatol. 2002;119:992–1007.

    Article  CAS  PubMed  Google Scholar 

  7. Dessinioti C, Katsambas AD. Hormonal therapy for acne: Why not as first line therapy? Facts and controversies. Clin Dermatol. 2010;28:17–23.

    PubMed  Google Scholar 

  8. Gollnick H, Cunliffe W, Berson D, et al. Management of acne. J Am Acad Dermatol. 2003;49:S20–5.

    Article  Google Scholar 

  9. Schmuth M, Watson RE, Deplewski D, et al. Nuclear hormone receptors in human skin. Horm Metab Res. 2007;39:96–105.

    Article  CAS  PubMed  Google Scholar 

  10. Zouboulis CC, Rabe T. Hormonal antiandrogens in acne treatment. JDDG. 2010;8:s60–74.

    Article  PubMed  Google Scholar 

  11. Zouboulis CC. Treatment of acne with anti-androgens: an evidence-based review. J Dtsch Dermatol Ges. 2003;1:535–46.

    Article  PubMed  Google Scholar 

  12. Gollnick H, Albring M, Brill K. Efficacité de l’acètate de cyprotèrone oral associé à l’ethinylestradiol dans le traitement de l’acné tardive de type facial. Ann Endocrinol. 1999;60:157–66.

    CAS  Google Scholar 

  13. Van Wayjen R, van den Ende A. Experience in the long-term treatment of patients with hirsutism and/or acne with cyproterone acetate-containing preparations: efficacy, metabolic, and endocrine effects. Exp Clin Endocrinol Diabetes. 1995;103:241–51.

    Article  PubMed  Google Scholar 

  14. Mallari R, Sinclair RD. Shortness of breath: an uncommon side-effect of cyproterone acetate in the treatment of androgenetic alopecia. Int J Dermatol. 2002;41:946–7.

    Article  PubMed  Google Scholar 

  15. Shaw JC. Low-dose adjunctive spironolactone in the treatment of acne in a retrospective analysis of 85 consecutively treated patients. J Am Acad Dermatol. 2000;43:498–502.

    Article  CAS  PubMed  Google Scholar 

  16. Akamatsu H, Zouboulis CC, Orfanos CE. Spironolactone directly inhibits proliferation of cultured human facial sebocytes and acts antagonistically to testosterone and 5-alpha-dihydrotestosterone in vitro. J Invest Dermatol. 1993;100:660–2.

    Article  CAS  PubMed  Google Scholar 

  17. Thiboutot D. Acne: hormonal concepts. Clin Dermatol. 2004;22:419–28.

    Article  PubMed  Google Scholar 

  18. Frangos J, Alavian CN, Kimball AB. Acne and oral contraceptives: update on women’s health screening guidelines. J Am Acad Dermatol. 2008;58:781–6.

    Article  PubMed  Google Scholar 

  19. Thorneycroft I. Evolution of progestins. Focus on the novel progestin drospirenone. J Reprod Med. 2002;47 Suppl 11:975–80.

    CAS  PubMed  Google Scholar 

  20. Lucky AW, Henderson TA, Olson WH, et al. Effectiveness of norgestimate and ethinyl estradiol in treating moderate acne vulgaris. J Am Acad Dermatol. 1997;37:746–54.

    Article  CAS  PubMed  Google Scholar 

  21. Junkins-Hopkins JM. Hormone therapy for acne. J Am Acad Dermatol. 2010;62:486–8.

    Article  PubMed  Google Scholar 

  22. Leyden J, Shalita A, Hordinsky M, et al. Efficacy of a low-dose oral contraceptive containing 20 μg of ethinyl estradiol and 100 μg of levonorgestrel for the treatment of moderate acne: a randomized, placebo-controlled trial. J Am Acad Dermatol. 2002;47:399–409.

    Article  PubMed  Google Scholar 

  23. Thiboutot D, Archer DF, Lemay A, et al. A randomized, controlled trial of a low-dose contraceptive 20 microg of ethinyl estradiol and 100 microg of levonorgestrel for acne treatment. Fertil Steril. 2001;76:461–8.

    Article  CAS  PubMed  Google Scholar 

  24. Thomeycroft H, Gollnick H, Schellschmidt I. Superiority of a combined contraceptive containing drospirenone to a triphasic preparation containing norgestimate in acne treatment. Cutis. 2004;74:123–30.

    Google Scholar 

  25. Maloney JM, Dietze Jr P, Watson D, et al. A randomized controlled trial of a low-dose combined oral contraceptive containing 3 mg drospirenone plus 20 microg ethinylestradiol in the treatment of acne vulgaris: lesion counts, investigator ratings and subject self-assessment. J Drugs Dermatol. 2009;8:837–44.

    PubMed  Google Scholar 

  26. DeRossi SS, Hersh EV. Antibiotics and oral contraceptives. Dent Clin North Am. 2002;46:653–4.

    Article  PubMed  Google Scholar 

  27. Helms SE, Bredle DL, Zajic J, et al. Oral contraceptive failure rates and oral antibiotics. J Am Acad Dermatol. 1997;36:705–10.

    Article  CAS  PubMed  Google Scholar 

  28. London BM, Lookingbill DP. Frequency of pregnancy in acne patients taking oral antibiotics and oral contraceptives. Arch Dermatol. 1994;130:392–3.

    Article  CAS  PubMed  Google Scholar 

  29. Dessinioti C, Katsambas AD. Congenital adrenal hyperplasia. Dermatoendocrinology. 2009;1:1–5.

    Article  Google Scholar 

  30. Degitz K, Placzek M, Arnold B, et al. Congenital adrenal hyperplasia and acne in male patients. Br J Dermatol. 2003;148:1263–6.

    Article  CAS  PubMed  Google Scholar 

  31. Chen W, Zouboulis CC, Orfanos CE. The 5 alpha-reductase system and its inhibitors. Recent development and its perspective in treating androgen-dependent skin disorders. Dermatology. 1996;193:177–84.

    Article  CAS  PubMed  Google Scholar 

  32. Thiboutot D, Harris G, Iles V, et al. Activity of the type 1 5 alpha-reductase exhibits regional differences in isolated sebaceous glands and whole skin. J Invest Dermatol. 1995;105:209–14.

    Article  CAS  PubMed  Google Scholar 

  33. Zouboulis CC. Acne and sebaceous gland function. Clin Dermatol. 2004;22:360–6.

    Article  PubMed  Google Scholar 

  34. Orfanos CE, Adler YD, Zouboulis CC. The SAHA sydnrome. Horm Res. 2000;54:251–8.

    Article  CAS  PubMed  Google Scholar 

  35. Zouboulis CC, Degitz K. Androgen action on human skin-from basic research to clinical significance. Exp Dermatol. 2004;13 Suppl 4:5–10.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Dermatology, Andreas Syngros Hospital, National and Capodistrian University of Athens, Athens, Greece

    Clio Dessinioti

  2. Departments of Dermatology, Venereology, Allergology and Immunology, Dessau Medical Center, Dessau, Germany

    Christos C. Zouboulis

Authors
  1. Clio Dessinioti
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Christos C. Zouboulis
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Clio Dessinioti .

Editor information

Editors and Affiliations

  1. Departments of Dermatology, Venereology, Allergology, and Immunology, Dessau Medical Center, Dessau, Germany

    Christos C. Zouboulis

  2. Department of Dermatology, Andreas Syngros Hospital, University of Athens, Athens, Greece

    Andreas D. Katsambas

  3. Department of Dermatology, University of Pennsylvania, Philadelphia, Pennsylvania, USA

    Albert M. Kligman

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Dessinioti, C., Zouboulis, C.C. (2014). Hormonal Therapy for Acne. In: Zouboulis, C., Katsambas, A., Kligman, A. (eds) Pathogenesis and Treatment of Acne and Rosacea. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-69375-8_64

Download citation

  • DOI: https://doi.org/10.1007/978-3-540-69375-8_64

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-69374-1

  • Online ISBN: 978-3-540-69375-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation